Volitionrx Ltd financial data

Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
Location
1489 West Warm Springs Road, Suite 110, Henderson, NV
State of incorporation
DE
Fiscal year end
December 31
Former names
STANDARD CAPITAL CORP (to 9/29/2011)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 49 % -45.5%
Debt-to-equity -274 % -112%
Return On Equity 257 %
Return On Assets -167 % -8.54%
Operating Margin -3.36K % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92.1M shares +17.9%
Common Stock, Shares, Outstanding 82.9M shares +6.13%
Entity Public Float 82.2M USD +12%
Common Stock, Value, Issued 82.9K USD +6.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 977K USD +88.3%
Research and Development Expense 17.5M USD -6.81%
Selling and Marketing Expense 6.53M USD -0.82%
General and Administrative Expense 9.68M USD -0.38%
Costs and Expenses 803K USD
Operating Income (Loss) -32.8M USD +5.29%
Nonoperating Income (Expense) 51K USD -96.3%
Net Income (Loss) Attributable to Parent -32.8M USD +2.35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.8M USD +17.6%
Accounts Receivable, after Allowance for Credit Loss, Current 166K USD -15.4%
Other Assets, Current 351K USD -35.3%
Assets, Current 7.35M USD -65.8%
Property, Plant and Equipment, Net 4.88M USD -10.6%
Operating Lease, Right-of-Use Asset 512K USD -3.46%
Intangible Assets, Net (Excluding Goodwill) 215K USD +137%
Assets 13.1M USD -52.6%
Accounts Payable, Current 3.35M USD -4.14%
Accrued Liabilities, Current 3.23M USD -4.83%
Contract with Customer, Liability, Current 101K USD
Liabilities, Current 31M USD +64.7%
Operating Lease, Liability, Noncurrent 351K USD +3.08%
Liabilities 36M USD +60.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 282K USD +35.5%
Retained Earnings (Accumulated Deficit) -218M USD -17.5%
Stockholders' Equity Attributable to Parent -21.8M USD -473%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -22.9M USD -547%
Liabilities and Equity 13.1M USD -52.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.34M USD +4.6%
Net Cash Provided by (Used in) Financing Activities -209K USD -103%
Net Cash Provided by (Used in) Investing Activities -78.8K USD +60.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 82.9M shares +6.13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.96M USD -946%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6M USD -69.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 77.2K USD +50.5%
Operating Lease, Liability 709K USD
Depreciation 278K USD +10.6%
Payments to Acquire Property, Plant, and Equipment 28.8K USD -85.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.7M USD +2.67%
Property, Plant and Equipment, Gross 9.48M USD +4.4%
Operating Lease, Liability, Current 190K USD -12.9%
Additional Paid in Capital 196M USD +2.46%
Amortization of Intangible Assets 14.3K USD -32.3%
Share-based Payment Arrangement, Expense 335K USD -32.2%
Interest Expense 155K USD +11.9%